Ziya Kapran
Ziya Kapran has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Akın Çakır
University of Health Sciences Türkiye, İstanbul Prof. Dr. Cemil Taşcıoğlu City Hospital, Clinic of Ophthalmology, İstanbul, Türkiye
1 shared publication - Anıl Korkmaz
University of Health Sciences, Beyoglu Eye Training and Research Hospital
1 shared publication - Burak Erden
Department of Ophthalmology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey
1 shared publication - Doğukan Cömerter
Department of Ophthalmology, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
1 shared publication - Ebru Görgün
Etiler Dünya Göz Hastanesi, Nispetiye Cd. Yanarsu Sk. No:1, Etiler, Istanbul, Türkiye
1 shared publication - Ece Ozal
Department of Ophthalmology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 23 June 2026
- Published by Springer Nature in Ophthalmology and Therapy
Intravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye
The aim of this study was to evaluate the real-world efficacy and safety of intravitreal faricimab for macular edema (ME) secondary to retinal vein occlusion (RVO) across a multicenter cohort with up to 52 weeks of follow-up. Data from 17 centers across Türkiye were retrospectively analyzed between 22 November 2024 and 1 March 2026. Patients with branch RVO (BRVO) or central RVO (CRVO) complicated by ME who received at least one intravitreal faricimab injection and had complete ophthalmic and optical coherence tomography (OCT) data with a minimum 4-week follow-up were included. Demographics, diagnosis, prior treatments, best-corrected visual acuity (BCVA; decimal converted to logMAR), central macular thickness (CMT), intraocular pressure (IOP), injection number, follow-up duration, and ocular/systemic adverse events were recorded at baseline, day 7, monthly after each of the first three injections, and at the final visit. A total of 70 patients (37 BRVO [52.9%], 33 CRVO [47.1%]) were included, with a mean follow-up of 23.69 ± 8.54 weeks; 44 (62.8%) were treatment-naïve and 26 (37.2%) were switch patients. When comparing baseline and final visits, treatment-naïve patients showed a mean CMT reduction of 306.9 ± 231.3 µm (from 594.1 ± 206.9 µm at baseline to 287.2 ± 89.9 µm at final visit; p < 0.001), while switch patients demonstrated a mean CMT reduction of 290.6 ± 114.3 µm (from 562.1 ± 107.3 to 271.5 ± 90.7 µm; p < 0.001). The mean logMAR BCVA gain was 0.77 (p < 0.001) in naïve and 0.38 (p < 0.001) in switch patients. IOP remained stable throughout, and no serious ocular or systemic adverse events were recorded. Faricimab demonstrated rapid anatomical and functional improvements in the RVO cohort, evident as early as day 7 after the initial injection. These findings support faricimab as a potent and reliable therapeutic option across both RVO subtypes in routine clinical practice.
- 23 June 2026
- Published by Springer Nature in Ophthalmology and Therapy
Open AccessIntravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye
The aim of this study was to evaluate the real-world efficacy and safety of intravitreal faricimab for macular edema (ME) secondary to retinal vein occlusion (RVO) across a multicenter cohort with up to 52 weeks of follow-up. Data from 17 centers across Türkiye were retrospectively analyzed between 22 November 2024 and 1 March 2026. Patients with branch RVO (BRVO) or central RVO (CRVO) complicated by ME who received at least one intravitreal faricimab injection and had complete ophthalmic and optical coherence tomography (OCT) data with a minimum 4-week follow-up were included. Demographics, diagnosis, prior treatments, best-corrected visual acuity (BCVA; decimal converted to logMAR), central macular thickness (CMT), intraocular pressure (IOP), injection number, follow-up duration, and ocular/systemic adverse events were recorded at baseline, day 7, monthly after each of the first three injections, and at the final visit. A total of 70 patients (37 BRVO [52.9%], 33 CRVO [47.1%]) were included, with a mean follow-up of 23.69 ± 8.54 weeks; 44 (62.8%) were treatment-naïve and 26 (37.2%) were switch patients. When comparing baseline and final visits, treatment-naïve patients showed a mean CMT reduction of 306.9 ± 231.3 µm (from 594.1 ± 206.9 µm at baseline to 287.2 ± 89.9 µm at final visit; p < 0.001), while switch patients demonstrated a mean CMT reduction of 290.6 ± 114.3 µm (from 562.1 ± 107.3 to 271.5 ± 90.7 µm; p < 0.001). The mean logMAR BCVA gain was 0.77 (p < 0.001) in naïve and 0.38 (p < 0.001) in switch patients. IOP remained stable throughout, and no serious ocular or systemic adverse events were recorded. Faricimab demonstrated rapid anatomical and functional improvements in the RVO cohort, evident as early as day 7 after the initial injection. These findings support faricimab as a potent and reliable therapeutic option across both RVO subtypes in routine clinical practice.
- Open Access
- 27 October 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 55 (5) , 256-259
Internal Drainage of Subretinal Fluid Using 25/32 Gauge Cannula in Eyes with Rhegmatogenous Retinal Detachment
Internal Drainage of Subretinal Fluid Using 25/32 Gauge Cannula in Eyes with Rhegmatogenous Retinal Detachment - Turkish Journal of Ophthalmology
- 27 October 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 55 (5) , 256-259
Open AccessInternal Drainage of Subretinal Fluid Using 25/32 Gauge Cannula in Eyes with Rhegmatogenous Retinal Detachment
Internal Drainage of Subretinal Fluid Using 25/32 Gauge Cannula in Eyes with Rhegmatogenous Retinal Detachment - Turkish Journal of Ophthalmology
- Open Access
- 1 April 2022
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 52 (2) , 119-124
Heavy Silicone Oil as an Endotamponade in Recurrent or Complicated Retinal Detachment and Macular Hole
Objectives: To evaluate the efficacy and safety of heavy silicone oil as an endotamponade in patients with recurrent or complicated retinal detachment and macular hole. Materials and Methods: Nineteen eyes of 19 patients who underwent heavy silicone oil endotamponade for different indications were included in the study and evaluated by retrospective chart review. At each visit, patients underwent detailed ophthalmological examination and anatomical and functional outcomes, silicone oil emulsification, intraocular inflammation, presence of proliferative vitreoretinopathy, preoperative and postoperative visual acuity, and postoperative complications were recorded. Results: The study included 19 eyes of 19 consecutive patients: 13 women (68.4%) and 6 men (31.6%). The patients' median age was 60 years (interquartile range [IQR]: 44-70 years) and the median follow-up time was 19 months (IQR: 9-31 months). Indications for heavy silicone oil endotamponade were recurrent retinal detachment in 11 eyes (57.8%), inferior retinal detachment in 5 eyes (26.3%), inferior rhegmatogenous retinal detachment, recurrent macular hole in 2 patients (10.5%), and macular hole in 1 patient (5.2%). Median best corrected visual acuity was 2 logMAR (IQR: 1-2.6) preoperatively and 0.99 logMAR (IQR: 0.4-2) postoperatively (p<0.001). Postoperative anatomical success was achieved in all patients. Densiron 68 was used for endotamponade in 14 patients (73.7%), Densiron XTRA in 3 patients (15.8%), and AlaHeavy 1.07 in 2 patients. Heavy silicone oil emulsification was observed in only 3 patients (15.8%). Conclusion: Although heavy silicone oil has limitations as an endotamponade, such as intraocular pressure increase, emulsification, intraocular inflammation, and the risk of complications during removal, it is a safe and effective alternative in eyes requiring inferior retinal tamponade for indications like proliferative vitreoretinopathy and recurrent macular holes.
- 1 April 2022
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 52 (2) , 119-124
Open AccessHeavy Silicone Oil as an Endotamponade in Recurrent or Complicated Retinal Detachment and Macular Hole
Objectives: To evaluate the efficacy and safety of heavy silicone oil as an endotamponade in patients with recurrent or complicated retinal detachment and macular hole. Materials and Methods: Nineteen eyes of 19 patients who underwent heavy silicone oil endotamponade for different indications were included in the study and evaluated by retrospective chart review. At each visit, patients underwent detailed ophthalmological examination and anatomical and functional outcomes, silicone oil emulsification, intraocular inflammation, presence of proliferative vitreoretinopathy, preoperative and postoperative visual acuity, and postoperative complications were recorded. Results: The study included 19 eyes of 19 consecutive patients: 13 women (68.4%) and 6 men (31.6%). The patients' median age was 60 years (interquartile range [IQR]: 44-70 years) and the median follow-up time was 19 months (IQR: 9-31 months). Indications for heavy silicone oil endotamponade were recurrent retinal detachment in 11 eyes (57.8%), inferior retinal detachment in 5 eyes (26.3%), inferior rhegmatogenous retinal detachment, recurrent macular hole in 2 patients (10.5%), and macular hole in 1 patient (5.2%). Median best corrected visual acuity was 2 logMAR (IQR: 1-2.6) preoperatively and 0.99 logMAR (IQR: 0.4-2) postoperatively (p<0.001). Postoperative anatomical success was achieved in all patients. Densiron 68 was used for endotamponade in 14 patients (73.7%), Densiron XTRA in 3 patients (15.8%), and AlaHeavy 1.07 in 2 patients. Heavy silicone oil emulsification was observed in only 3 patients (15.8%). Conclusion: Although heavy silicone oil has limitations as an endotamponade, such as intraocular pressure increase, emulsification, intraocular inflammation, and the risk of complications during removal, it is a safe and effective alternative in eyes requiring inferior retinal tamponade for indications like proliferative vitreoretinopathy and recurrent macular holes.
- 1 March 2020
- Published by Phoenix Medical Journal in Phoenix Medical Journal
- Vol. 2 (1) , 11-15
İdiyopatik Makula Deliği Tedavisinde 25 Gauge Pars Plana Vitrektomi Sonuçlarımız
Amaç: İdiyopatik makula deliği cerrahi tedavisinde uygulanan 25 gauge (G) pars plana vitrektomi (PPV) cerrahisinin anatomik ve fonksiyonel başarısını ve komplikasyonlarını değerlendirmek. Gereç ve Yöntemler: Mart 2005 – Mayıs 2008 tarihleri arasında hastanemizde makula deliği nedeniyle vitreoretinal cerrahi geçiren 28 hastanın 30 gözüne ait veriler retrospektif olarak incelendi ve olgular anatomik ve fonksiyonel başarı ile görülen komplikasyonlar açısından değerlendirildi.Bulgular: Yasları 40 ile 84 arasında değişen (ortalama 65 ± 10,68 yıl) olguların 18’i (%64,2) kadın ve 10’u (%35,8) erkekti. 22 olguda (%73,3) evre 3, 6 olguda (%20) evre 4, 2 olguda ise (%6,7) evre 2 makuler delik mevcut idi. Cerrahi öncesi en iyi düzeltilmiş görme keskinlikleri (EDGK) ortalama 0,12 ± 0,09 (logMAR 0,98 ± 0,33, 0,05 – 0,4 arası) olarak saptandı. Makula deliklerinin süresi ortalama 9,55 ± 8,97 ay idi. (1 – 24 ay) 25 G PPV cerrahisi sonrası ortalama 13,81 ± 9,44 ay (1-30 ay) takip edilen 30 gözün 29 ‘unda (%96,6) anatomik başarı elde edildi. Olguların cerrahi öncesi ve sonrası EDGK arasındaki fark istatistiksel olarak anlamlıydı (p<0,05). Ameliyat sonrası, 9 olguda (%30) retina pigment epiteli (RPE) değişiklikleri, 8 olguda (%26,67) katarakt, 3 olguda (%10) hipotoni ve 1 olguda (%3,34) retina dekolmanı gelişti. Sonuç: İdiyopatik makula deliği cerrahi tedavisinde 25 G sütürsüz vitrektomi tekniği hem anatomik hem fonksiyonel iyileşme açısından etkili bulunmuştur.
- 1 March 2020
- Published by Phoenix Medical Journal in Phoenix Medical Journal
- Vol. 2 (1) , 11-15
İdiyopatik Makula Deliği Tedavisinde 25 Gauge Pars Plana Vitrektomi Sonuçlarımız
Amaç: İdiyopatik makula deliği cerrahi tedavisinde uygulanan 25 gauge (G) pars plana vitrektomi (PPV) cerrahisinin anatomik ve fonksiyonel başarısını ve komplikasyonlarını değerlendirmek. Gereç ve Yöntemler: Mart 2005 – Mayıs 2008 tarihleri arasında hastanemizde makula deliği nedeniyle vitreoretinal cerrahi geçiren 28 hastanın 30 gözüne ait veriler retrospektif olarak incelendi ve olgular anatomik ve fonksiyonel başarı ile görülen komplikasyonlar açısından değerlendirildi.Bulgular: Yasları 40 ile 84 arasında değişen (ortalama 65 ± 10,68 yıl) olguların 18’i (%64,2) kadın ve 10’u (%35,8) erkekti. 22 olguda (%73,3) evre 3, 6 olguda (%20) evre 4, 2 olguda ise (%6,7) evre 2 makuler delik mevcut idi. Cerrahi öncesi en iyi düzeltilmiş görme keskinlikleri (EDGK) ortalama 0,12 ± 0,09 (logMAR 0,98 ± 0,33, 0,05 – 0,4 arası) olarak saptandı. Makula deliklerinin süresi ortalama 9,55 ± 8,97 ay idi. (1 – 24 ay) 25 G PPV cerrahisi sonrası ortalama 13,81 ± 9,44 ay (1-30 ay) takip edilen 30 gözün 29 ‘unda (%96,6) anatomik başarı elde edildi. Olguların cerrahi öncesi ve sonrası EDGK arasındaki fark istatistiksel olarak anlamlıydı (p<0,05). Ameliyat sonrası, 9 olguda (%30) retina pigment epiteli (RPE) değişiklikleri, 8 olguda (%26,67) katarakt, 3 olguda (%10) hipotoni ve 1 olguda (%3,34) retina dekolmanı gelişti. Sonuç: İdiyopatik makula deliği cerrahi tedavisinde 25 G sütürsüz vitrektomi tekniği hem anatomik hem fonksiyonel iyileşme açısından etkili bulunmuştur.
- 1 September 2007
- Published by Wolters Kluwer Health in Retina
- Vol. 27 (7) , 971-973
THE USE OF BLOOD CULTURE BOTTLES IN ENDOPHTHALMITIS
To study the use of blood culture bottles for culturing vitreous specimens in acute-onset postoperative infectious endophthalmitis cases. Forty-eight eyes of 48 patients with mean age of 66.4 +/- 14.7 years with postoperative endophthalmitis that occurred within 6 weeks after ocular surgery, presenting from June 2001 to January 2005, were retrospectively studied. Vitreous fluid specimens of these patients were cultured in blood culture bottles. The measured outcome is the yield of positive culture. Vitreous specimens yielded positive in 34 of 48 (70.8%) eyes with blood culture bottles. The most common organism isolated was Staphylococcus epidermidis in 17.6% (6/34) of cases. The direct inoculation of vitreous specimens into the blood culture bottles is easy to perform, with a high yield positive rate (70.8%). It may be an alternative to conventional culture media for culturing vitreous specimen in infectious endophthalmitis especially in clinics or hospitals that are unable to have adequate microbiology laboratory facilities.
- 1 September 2007
- Published by Wolters Kluwer Health in Retina
- Vol. 27 (7) , 971-973
THE USE OF BLOOD CULTURE BOTTLES IN ENDOPHTHALMITIS
To study the use of blood culture bottles for culturing vitreous specimens in acute-onset postoperative infectious endophthalmitis cases. Forty-eight eyes of 48 patients with mean age of 66.4 +/- 14.7 years with postoperative endophthalmitis that occurred within 6 weeks after ocular surgery, presenting from June 2001 to January 2005, were retrospectively studied. Vitreous fluid specimens of these patients were cultured in blood culture bottles. The measured outcome is the yield of positive culture. Vitreous specimens yielded positive in 34 of 48 (70.8%) eyes with blood culture bottles. The most common organism isolated was Staphylococcus epidermidis in 17.6% (6/34) of cases. The direct inoculation of vitreous specimens into the blood culture bottles is easy to perform, with a high yield positive rate (70.8%). It may be an alternative to conventional culture media for culturing vitreous specimen in infectious endophthalmitis especially in clinics or hospitals that are unable to have adequate microbiology laboratory facilities.
- 1 March 2004
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 14 (2) , 156-158
Pigmented Congenital Vitreous Cyst
Purpose: To describe the clinical findings in a case with a typical pigmented congenital vitreous cyst and to discuss its differential diagnosis. METHODS/CASE REPORT: A 24-year-old woman complaining of floaters and blurring of vision during eye movements in the right eye was examined. Results: A diagnosis of congenital vitreous cyst was made after detailed viteoretinal examination, B-scan ultrasonography (eye and abdomen), computerized tomography of brain, chest radiogram, serologic tests for Echinococcosis and Cysticercosis in the serum, and complete blood count for eosinophilia. Clinical presentation and the patient's complaints remained unchanged during 3 years of follow-up. CONCLUSIONS: Congenital vitreous cysts are benign lesions. Differential diagnosis from acquired cysts requires careful clinical examination and appropriate laboratory tests.
- 1 March 2004
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 14 (2) , 156-158
Pigmented Congenital Vitreous Cyst
Purpose: To describe the clinical findings in a case with a typical pigmented congenital vitreous cyst and to discuss its differential diagnosis. METHODS/CASE REPORT: A 24-year-old woman complaining of floaters and blurring of vision during eye movements in the right eye was examined. Results: A diagnosis of congenital vitreous cyst was made after detailed viteoretinal examination, B-scan ultrasonography (eye and abdomen), computerized tomography of brain, chest radiogram, serologic tests for Echinococcosis and Cysticercosis in the serum, and complete blood count for eosinophilia. Clinical presentation and the patient's complaints remained unchanged during 3 years of follow-up. CONCLUSIONS: Congenital vitreous cysts are benign lesions. Differential diagnosis from acquired cysts requires careful clinical examination and appropriate laboratory tests.
- 1 April 2001
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 11 (2) , 166-170
Recurrences of Retinal Detachment after Vitreoretinal Surgery, and Surgical Approach
Purpose: To investigate the causes and management of recurrences of complicated retinal detachment after vitreoretinal surgery. Methods: Vitreoretinal surgery was performed in 61 patients with complicated retinal detachment who were followed up for 4–24 (mean 7) months. Liquid perfluorocarbon (PFC) was used in all 61, silicone oil in 40 and perfluoropropane (C3F8) in 18 patients. Results: Retinal attachment was achieved in 58 patients (95%) during the first operation. Due to the recurrence of detachment 17 patients (29%) had to be operated for a second, 7 (12%) a third and 4 (7%) a fourth time. Anterior and posterior proliferative vitreoretinopathy, missed tear, retinal incarceration, subretinal membrane and perisilicone proliferation were the factors causing redetachment. Conclusions: The best anatomical and functional results are obtained by dissection of the anterior membranes. In order to properly remove the retinal periphery the crystalline or intraocular lens should be removed. Comparison of our results with others indicates that anatomical success depends, to a certain extent, on doing only one, radical operation on the pathology that leads to recurrence.
- 1 April 2001
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 11 (2) , 166-170
Recurrences of Retinal Detachment after Vitreoretinal Surgery, and Surgical Approach
Purpose: To investigate the causes and management of recurrences of complicated retinal detachment after vitreoretinal surgery. Methods: Vitreoretinal surgery was performed in 61 patients with complicated retinal detachment who were followed up for 4–24 (mean 7) months. Liquid perfluorocarbon (PFC) was used in all 61, silicone oil in 40 and perfluoropropane (C3F8) in 18 patients. Results: Retinal attachment was achieved in 58 patients (95%) during the first operation. Due to the recurrence of detachment 17 patients (29%) had to be operated for a second, 7 (12%) a third and 4 (7%) a fourth time. Anterior and posterior proliferative vitreoretinopathy, missed tear, retinal incarceration, subretinal membrane and perisilicone proliferation were the factors causing redetachment. Conclusions: The best anatomical and functional results are obtained by dissection of the anterior membranes. In order to properly remove the retinal periphery the crystalline or intraocular lens should be removed. Comparison of our results with others indicates that anatomical success depends, to a certain extent, on doing only one, radical operation on the pathology that leads to recurrence.